Genetic requirements for the survival of tubercle bacilli in primates

Journal of Infectious Diseases

Volumn 201, Issue 11, 2010, Pages 1743-1752

  Dutta, Noton K ^a   Mehra, Smriti ^a   Didier, Peter J ^a   Roy, Chad J ^a   Doyle, Lara A ^a   Alvarez, Xavier ^a   Ratterree, Marion ^a   Be, Nicholas A ^d   Lamichhane, Gyanu ^d   Jain, Sanjay K ^d   Lacey, Michelle R ^b   Lackner, Andrew A ^a,c   Kaushal, Deepak ^a,c  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; COBALAMIN; GLYCOPROTEIN P; GUANOSINE PHOSPHATE; HEAT SHOCK PROTEIN; HEMOLYSIN; MOLYBDENUM; NITRATE REDUCTASE; PEPTIDOGLYCAN; PHOSPHOLIPID; POLYKETIDE SYNTHASE; THIOSULFATE; TRIACYLGLYCEROL; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOSYNTHESIS; DNA REPAIR; IN VIVO STUDY; LUNG; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STEROL METABOLISM;

EID: 77951883143     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652497     Document Type: Article

References (37)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367:938-940.
2. Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007; 219: 37-54.
3. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003; 16:463-496.
4. Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 2003; 100:12989-12994.
5. Rengarajan J, Bloom BR, Rubin EJ. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 2005; 102:8327-8332.
6. Lamichhane G, Tyagi S, Bishai WR. Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect Immun 2005; 73:2533-2540.
7. Jain SK, Hernandez-Abanto SM, Cheng Q-J, et al. Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice. J Infect Dis 2007; 195:1634-1642.
8. Be NA, Lamichhane G, Grosset J, et al. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. J Infect Dis 2008; 198:1520-1528.
9. Walsh GP, Tan EV, Dela Cruz EC, et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 1996; 2:430436.
10. Capuano SV 3rd, Croix DA, Pawar S, et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 2003;71:5831-5844.
11. Lin PL, Pawar S, Myers A, et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006; 74: 3790-3803.
12. Lin PL, Rodgers M, Smith L, et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 2009;77:4631-4642.
13. Chen CY, Huang D, Wang RC, et al. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog 2009; 5: e1000392.
14. Lamichhane G, Zignol M, Blades NJ, et al. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2003; 100:7213-7218.
15. Hartings JM, Roy CJ. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 2004; 49:39-55.
16. Roy CJ, Pitt LML. Infectious disease aerobiology: aerosol challenge. Methods. In: Swearengen JL, ed. Biodefense: research methodology and animal models. Florida: CRC Press, 2005:61-75.
17. Larsen MH, Biermann K, Chen B, et al. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine 2009;27:4709-4717.
18. Gormus BJ, Blanchard JL, Alvarez XH, Didier PJ. Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 2004; 33:134-145.
19. Verreck FA, Vervenne RA, Kondova I, et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS ONE 2009;4:e5264.
20. Braibant M, Gilot P, Content J. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol Rev 2000; 24:449-467.
21. Park HD, Guinn KM, Harrell MI, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003;48:833-843.
22. Sirakova TD, Dubey VS, Kim HJ, Cynamon MH, Kolattukudy PE. The largest open reading frame (pksl2) in the Mycobacterium tuberculosis genome is involved in pathogenesis and dimycocerosyl phthiocerol synthesis. Infect Immun 2003;71:3794-3801.
23. Kumar A, Toledo JC, Patel RP, Lancaster JR, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor.Proc Natl Acad Sci USA 2007; 104:11568-11573.
24. Via LE, Ray SM, Carrillo J, et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008; 76:2333-2340.
25. Aly S, Wagner K, Keller C, et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 2006;210:298-305.
26. Kaufmann SH, Cole ST, Mizrahi V, Rubin E, Nathan C. Mycobacterium tuberculosis and the host response. J Exp Med 2005;201:1693-1697.
27. Tuberculist Web page. http://genolist.pasteur.fr/TubercuList/. Accessed 30 March 2010.
28. Senaratne RH, Sidders B, Sequeira P, et al. Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice. J Med Microbiol 2008;57:164-170.
29. Gioffré A, Infante E, Aguilar D, et al. Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect 2005; 7: 325-334.
30. Mehra S, Kaushal D. Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor sigmaH. J Bacteriol 2009; 191:3965-3980.
31. Kaushal D, Schroeder BG, Tyagi S, et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci USA 2002;99:8330-8335.
32. Mohn WW, van der Geize R, Stewart GR, et al. The actinobacterial mce4 locus encodes a steroid transporter. J Biol Chem 2008; 283:35368-35374.
33. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A 2008; 105:43764380.
34. Lamb DC, Kelly DE, Manning NJ, Kelly SL. A sterol biosynthetic pathway in Mycobacterium. FEBS Lett 1998;437:142-144.
35. Van der Geize R, Yam K, Heuser T, et al. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci USA 2007; 104:1947-1952.
36. Savvi S, Savvi S, Warner DF, et al. Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol 2008; 190:3886-3895.
37. Champion PAD, Stanley SA, Champion MM, Brown EJ, Cox JS. CTerminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science 2006;313:1632-1636.